Recombinant Gluconobacter oxydans Ferredoxin--NADP reductase (GOX0631)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order notes, and we will fulfill your request to the best of our ability.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates. Note: All proteins are shipped with standard blue ice packs. Dry ice shipping is available upon request but will incur additional charges. Please contact us in advance to arrange this.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Before opening, briefly centrifuge the vial to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C. Lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during manufacturing. The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
GOX0631; Ferredoxin--NADP reductase; FNR; Fd-NADP(+) reductase; EC 1.18.1.2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-340
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Gluconobacter oxydans (strain 621H) (Gluconobacter suboxydans)
Target Names
GOX0631
Target Protein Sequence
MTTAPQTLNT DVAIVGAGPT ALFAAFECGM LKLSCVLIDA LDSVGGQCAA LYPEKPIYDI PAHPAIEGGA LIEALEQQIA PFDVPRLLGS RVETLEGQRG AFTLKTARGD VITAKAVIIA AGAGAFGPNR PPLDGLEAYE RTGAVQYYVK KRADFTGKRV VVAGGGDSAL DWALSLSEVA AQVYLLHRRD RFRGAPETLS RIEQQIAAGK IEKVVPYQLH ALHGTDGVLS TVEVTTLEGT SRHIEADALL PFYGLSTDLG PIALWGLDTH RNTVPVTPAT LESSTPGIFA IGDVATYPGK LKLILQGFSE GAMAAHAIHA IVHPDTALHF EYSTSKGVPG
Uniprot No.

Q&A

What is the primary function of Ferredoxin-NADP reductase in Gluconobacter oxydans?

Ferredoxin-NADP+ reductases (FNRs) in G. oxydans, like other bacterial FNRs, function as redox flavoenzymes that participate in several metabolic pathways. Their primary role involves catalyzing electron transfer between ferredoxin and NADP+, playing a crucial part in the oxidative stress response . In obligatory aerobic bacteria like G. oxydans, FNRs help manage reactive oxygen species that are produced during aerobic metabolism. Gene expression studies have shown that the FNR family in G. oxydans responds to oxygen limitation conditions, suggesting an important role in adapting to varying oxygen levels .

How does GOX0631 differ structurally from other bacterial FNRs?

While specific structural data for GOX0631 is limited in the provided resources, bacterial FNRs like those in G. oxydans typically belong to subclass I bacterial FNRs. Research on similar FNRs, such as those in Xanthomonas axonopodis, has revealed unique structural features in the carboxy-terminal region that contribute to different functional properties compared to other subclass I bacterial FNRs . These structural differences influence substrate specificity and catalytic efficiency. To properly characterize GOX0631's structure:

  • Begin with sequence alignment analysis against well-characterized FNRs

  • Perform protein crystallography studies for 3D structural determination

  • Analyze conserved domains and potential binding sites

  • Assess structural differences that may indicate specialized functions in G. oxydans

What experimental approaches are recommended for measuring GOX0631 enzymatic activity?

For accurate measurement of GOX0631 activity, researchers should employ multiple complementary approaches:

MethodMeasurement ParameterTechnical Considerations
NADPH oxidation assayRate of NADPH consumptionMonitor at 340 nm; maintain anaerobic conditions
Cytochrome c reductionElectron transfer rateUse as artificial electron acceptor; monitor at 550 nm
Ferredoxin-dependent assaysNatural substrate kineticsRequires purified ferredoxin partner; assess with [4Fe-4S] spectral changes
ROS scavenging assessmentAntioxidant capabilityUse superoxide-generating agents like methyl viologen

When conducting these assays, researchers should control for pH, temperature, and ionic strength, as these factors significantly affect enzyme activity. For robust results, compare activity with known FNR standards and consider the potential natural ferredoxin partners in G. oxydans .

How can researchers effectively express and purify recombinant GOX0631 for structural and functional studies?

Expression and purification of recombinant GOX0631 requires careful optimization of multiple parameters:

  • Expression system selection: While commercial GOX0631 is available in yeast systems , researchers should consider E. coli BL21(DE3) for laboratory-scale production with the following enhancements:

    • Use of pET-based vectors with T7 promoter for high-level expression

    • Codon optimization for the expression host

    • Addition of a cleavable His-tag or Strep-tag for purification

  • Expression conditions optimization:

    • Induce at OD600 = 0.6-0.8 with 0.5 mM IPTG

    • Lower induction temperature to 18-20°C

    • Extend expression time to 16-18 hours to maximize soluble protein yield

    • Supplement media with riboflavin (10 μM) to ensure FAD cofactor availability

  • Purification protocol:

    • Initial capture with immobilized metal affinity chromatography

    • Secondary purification via ion exchange chromatography

    • Final polishing step using size exclusion chromatography

    • Maintain reducing conditions (1-5 mM DTT or β-mercaptoethanol) throughout purification

  • Quality assessment criteria:

    • UV-visible spectroscopy to confirm proper FAD incorporation (characteristic peaks at 380 and 450 nm)

    • Circular dichroism to verify proper folding

    • Size exclusion chromatography to ensure monodispersity

    • Activity assays to confirm functional integrity

This methodological approach has been successfully applied to similar FNRs and should yield high-quality protein suitable for both structural and functional studies .

What is the relationship between GOX0631 and the oxygen-responsive transcriptional regulator GoxR in G. oxydans?

The relationship between GOX0631 (Ferredoxin-NADP reductase) and GoxR (an FNR family transcriptional regulator) represents an intricate regulatory network controlling G. oxydans' response to oxygen limitation. ChAP-seq analysis with Strep-tagged GoxR has identified genomic binding sites of this regulator , which potentially includes the FNR gene GOX0631.

For researchers investigating this relationship, the following experimental approach is recommended:

  • Regulatory analysis:

    • Perform quantitative RT-PCR to measure GOX0631 expression under varying oxygen conditions

    • Compare expression levels between wild-type and ΔgoxR mutant strains

    • Conduct chromatin immunoprecipitation (ChIP) specifically targeting GoxR binding to the GOX0631 promoter region

  • Functional interaction:

    • Generate GOX0631 knockout strains and assess phenotypic changes under oxygen limitation

    • Evaluate oxygen consumption rates in wild-type versus mutant strains

    • Measure reactive oxygen species accumulation using fluorescent probes in various genetic backgrounds

  • Data integration:

    • Correlate GOX0631 expression patterns with GoxR binding events from ChAP-seq data

    • Develop computational models of the regulatory network

    • Use network analysis to identify additional components of the oxygen-responsive regulon

Understanding this relationship would provide critical insights into G. oxydans' adaptation to varying oxygen conditions, which is fundamental to its obligate aerobic metabolism .

What techniques should be employed to identify the natural ferredoxin partner(s) of GOX0631 in G. oxydans?

Identifying the natural ferredoxin partner(s) of GOX0631 requires a multi-faceted approach:

  • Genomic analysis:

    • Conduct comprehensive bioinformatic screening of the G. oxydans genome for ferredoxin-coding genes

    • Perform phylogenetic analysis to identify ferredoxins most closely related to known FNR partners

    • Analyze gene clustering and operonic arrangements for co-expression patterns

  • Protein-protein interaction studies:

    • Implement bacterial two-hybrid or yeast two-hybrid screening

    • Conduct pull-down assays using purified GOX0631 as bait

    • Perform isothermal titration calorimetry to quantify binding affinities

    • Utilize surface plasmon resonance to measure association and dissociation kinetics

  • Functional validation:

    • Express and purify candidate ferredoxins to assess spectral properties (particularly [4Fe-4S] clusters)

    • Measure electron transfer rates between purified ferredoxins and GOX0631

    • Develop reconstituted systems to assess complete electron transfer pathways

  • In vivo validation:

    • Generate ferredoxin knockout strains and assess impact on GOX0631-dependent processes

    • Perform co-expression analysis under various growth conditions

    • Conduct transcriptomic studies to identify coordinated expression patterns

This systematic approach has successfully identified ferredoxin partners in other bacterial systems, such as XAC1762 for Xac-FNR in Xanthomonas axonopodis .

How can GOX0631 be utilized in studies of oxidative stress response in G. oxydans?

GOX0631 serves as an excellent model for investigating oxidative stress responses in G. oxydans through several experimental approaches:

  • Expression analysis under oxidative stress:

    • Expose G. oxydans cultures to superoxide-generating agents such as methyl viologen and 2,3-dimethoxy-1,4-naphthoquinone

    • Measure GOX0631 expression using quantitative RT-PCR and Western blot analysis

    • Compare with other known oxidative stress response genes to establish regulatory patterns

    • Expected outcome: Similar to observations in other bacterial systems, GOX0631 expression likely increases approximately 2-2.5 fold under oxidative stress conditions

  • Functional knockout studies:

    • Generate GOX0631 deletion mutants

    • Assess growth characteristics under normal and oxidative stress conditions

    • Measure intracellular ROS levels using fluorescent probes

    • Evaluate survival rates following exposure to various oxidizing agents

  • Complementation experiments:

    • Perform cross-complementation studies with FNR genes from other bacteria

    • Test complementation of E. coli FNR knockout strains with GOX0631

    • Assess restoration of oxidative stress tolerance

  • Mechanistic investigations:

    • Identify specific ROS detoxification pathways involving GOX0631

    • Elucidate electron transfer pathways using purified components

    • Determine the role of GOX0631 in maintaining cellular redox balance

These approaches would provide comprehensive insights into G. oxydans' adaptation to its strictly aerobic lifestyle and mechanisms for managing oxidative stress .

What is the potential role of GOX0631 in rare earth element (REE) bioleaching applications of G. oxydans?

Recent research has demonstrated that G. oxydans possesses remarkable capabilities for REE-bioleaching, with genetic modifications yielding up to 73% improvement in efficiency . While direct evidence for GOX0631's involvement in REE-bioleaching is not explicitly stated in the provided materials, its role as a redox enzyme suggests potential contributions to this process:

  • Redox balance during acidification:

    • G. oxydans' REE-bioleaching capability relies on acidification through incomplete oxidation of glucose

    • FNRs like GOX0631 may contribute to maintaining redox balance during high-rate oxidation processes

    • Research methodology: Compare REE-bioleaching efficiency between wild-type and GOX0631 knockout strains

  • Integration with engineered bioleaching strains:

    • Current high-efficiency REE-bioleaching strains combine pstS deletion with mgdh overexpression

    • Investigate potential synergistic effects of GOX0631 overexpression in these backgrounds

    • Experimental approach: Generate triple-modified strains and assess bioleaching parameters

  • Oxidative stress management during bioleaching:

    • REE-bioleaching conditions likely generate oxidative stress

    • GOX0631's role in oxidative stress response may be crucial for maintaining cellular viability

    • Research design: Monitor oxidative stress markers and GOX0631 expression during bioleaching processes

  • Electron transfer to metal substrates:

    • FNRs may participate in direct or indirect electron transfer to metal substrates

    • Methodology: Electrochemical studies using purified GOX0631 with REE-containing substrates

This research direction represents an important intersection between fundamental enzyme function and applied biotechnology with significant environmental implications .

How can computational approaches enhance our understanding of GOX0631 structure-function relationships?

Modern computational tools offer powerful approaches to elucidate GOX0631 structure-function relationships:

  • Homology modeling and molecular dynamics:

    • Generate 3D structural models based on crystallized bacterial FNRs

    • Perform molecular dynamics simulations to assess conformational changes during catalysis

    • Identify key residues involved in cofactor binding and substrate interactions

    • Simulation parameters: 100-200 ns simulations in explicit solvent with AMBER or CHARMM force fields

  • Quantum mechanical/molecular mechanical (QM/MM) calculations:

    • Model electron transfer reactions at the FAD center

    • Calculate energy barriers for catalytic steps

    • Predict effects of specific mutations on catalytic efficiency

    • Methodology: Combined DFT and molecular mechanics approaches

  • Systems biology modeling:

    • Integrate GOX0631 into genome-scale metabolic models of G. oxydans

    • Perform flux balance analysis to predict metabolic impacts of GOX0631 modulation

    • Model cellular responses to varying oxygen conditions

    • Approach: Constraint-based modeling using COBRA toolbox

  • Machine learning applications:

    • Develop predictive models for substrate specificity based on protein sequence

    • Identify patterns in expression data that correlate with functional outcomes

    • Generate hypotheses for targeted experimental validation

    • Methods: Use supervised learning algorithms trained on existing FNR functional data

These computational approaches complement experimental studies and can guide rational enzyme engineering efforts to enhance GOX0631 performance for biotechnological applications .

What are common difficulties in working with recombinant GOX0631 and how can they be addressed?

Researchers working with recombinant GOX0631 often encounter several technical challenges:

ChallengePossible CausesRecommended Solutions
Low solubilityImproper folding, aggregationLower expression temperature (16-18°C), use solubility tags (SUMO, MBP), include glycerol (10%) in buffers
Loss of FAD cofactorBuffer conditions, exposure to lightSupplement purification buffers with 10 μM FAD, minimize light exposure, avoid freeze-thaw cycles
Poor enzymatic activityInactive protein, improper redox stateInclude reducing agents (1-5 mM DTT), verify FAD incorporation spectroscopically, ensure anaerobic conditions during assays
Instability during storageOxidation, proteolysisAdd glycerol (20%), store at -80°C in small aliquots, include protease inhibitors
Inconsistent activity measurementsAssay conditions, substrate qualityStandardize assay conditions, use freshly prepared substrates, include positive controls

Additional considerations:

  • When generating antibodies against GOX0631, target unique epitopes that differentiate it from other bacterial FNRs

  • For crystallization attempts, screening with FAD analogs may improve crystal quality

  • During kinetic studies, ensure that measurements are taken in the linear range of the enzyme activity

These troubleshooting strategies derive from experience with similar FNR enzymes and should be adapted based on specific GOX0631 properties observed during experimentation .

How should researchers design experiments to distinguish between the multiple potential physiological roles of GOX0631?

FNRs like GOX0631 often serve multiple physiological roles, making it challenging to dissect their specific functions. A comprehensive experimental design to distinguish between these roles should include:

  • Genetic approach:

    • Generate clean GOX0631 deletion mutants using CRISPR-Cas9 or traditional homologous recombination

    • Create complementation strains with wild-type and site-directed mutants of GOX0631

    • Develop inducible expression systems to control GOX0631 levels precisely

    • Design partial function mutants that affect specific activities

  • Physiological profiling:

    • Assess growth under various stress conditions (oxidative, nitrosative, metal)

    • Measure survival rates following exposure to different ROS-generating compounds

    • Monitor metabolic flux using 13C-labeled substrates

    • Evaluate gene expression patterns under different growth conditions

  • Biochemical dissection:

    • Perform in vitro reconstitution of potential electron transport chains

    • Measure electron transfer rates with different potential physiological partners

    • Assess affinity for various ferredoxin partners under different redox conditions

    • Use site-directed mutagenesis to selectively impair specific functions

  • Multi-omics integration:

    • Combine transcriptomics, proteomics, and metabolomics data

    • Identify condition-specific correlations between GOX0631 and other cellular components

    • Develop predictive models of GOX0631 function based on integrated datasets

This systematic approach allows researchers to distinguish between the enzyme's roles in oxidative stress response, general metabolism, and potential specialized functions in G. oxydans .

What emerging technologies could advance our understanding of GOX0631 function and regulation?

Several cutting-edge technologies hold promise for elucidating GOX0631 function and regulation:

  • Cryo-electron microscopy:

    • Achieve high-resolution structures of GOX0631 in complex with ferredoxin partners

    • Visualize conformational changes during catalysis

    • Resolve structures of GOX0631 within larger protein complexes

  • Single-molecule techniques:

    • Track electron transfer events in real-time

    • Measure conformational dynamics during catalysis

    • Assess heterogeneity in enzyme behavior

  • Genome editing technologies:

    • Apply CRISPR interference for temporal regulation of GOX0631 expression

    • Create genomic reporter fusions to monitor expression dynamics

    • Develop high-throughput mutagenesis platforms for structure-function analysis

  • Advanced spectroscopic methods:

    • Implement time-resolved spectroscopy to capture catalytic intermediates

    • Use electron paramagnetic resonance to characterize radical species

    • Apply Mössbauer spectroscopy to characterize iron-sulfur clusters in partner ferredoxins

  • Synthetic biology approaches:

    • Design orthogonal electron transfer pathways incorporating GOX0631

    • Create biosensors based on GOX0631 redox activity

    • Engineer GOX0631 variants with enhanced or altered substrate specificity

These technologies would substantially advance our understanding of both fundamental FNR biology and potential biotechnological applications of GOX0631 .

How might comparative analysis of GOX0631 with FNRs from other bacteria inform our understanding of its specialized functions in G. oxydans?

Comparative analysis represents a powerful approach to understanding GOX0631's specialized functions:

  • Phylogenetic analysis framework:

    • Construct comprehensive phylogenetic trees of bacterial FNRs

    • Identify evolutionary relationships between GOX0631 and other bacterial FNRs

    • Correlate FNR clades with bacterial lifestyle (aerobic, anaerobic, facultative)

    • Map key functional residues across evolutionary history

  • Structural comparison methodology:

    • Analyze conservation patterns in protein domains

    • Identify G. oxydans-specific structural features

    • Compare binding pocket architecture across bacterial FNRs

    • Assess differences in oligomerization interfaces

  • Functional complementation approach:

    • Test ability of GOX0631 to complement FNR-deficient strains from diverse bacteria

    • Evaluate heterologous FNRs for their ability to complement GOX0631 knockout in G. oxydans

    • Measure kinetic parameters with ferredoxins from various bacterial sources

    • Create chimeric enzymes to map domain-specific functions

  • Regulatory network comparison:

    • Compare expression patterns of FNR genes across bacterial species

    • Identify conserved and divergent regulatory elements

    • Correlate regulatory differences with metabolic capabilities

    • Develop predictive models of FNR function based on genomic context

This comparative approach would highlight adaptations specific to G. oxydans' obligate aerobic lifestyle and unique metabolic capabilities, particularly its incomplete oxidation of substrates which is central to its biotechnological applications .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.